» Articles » PMID: 36074433

Autologous Platelet Concentrates for Facial Rejuvenation

Overview
Journal J Appl Oral Sci
Specialty Dentistry
Date 2022 Sep 8
PMID 36074433
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Autologous platelet concentrates (APCs) are promising therapeutic agents in facial rejuvenation since they are a great source of cytokines, growth factors and other biologically active substances. Obtained from the patient's blood, they have the advantages of reducing immunological reactions, making the procedure safer, well tolerated, with minimal adverse effects and lower cost. Currently, they are used for facial rejuvenation both in combination with microneedling and in mesotherapy techniques, as well as to treat facial acne scars, melasma and wounds after laser ablative treatments. This review summarizes current knowledge on the use of APCs, ranging from basic concepts related to their composition and mechanisms of action to up-to-date information on their clinical efficacy.

Methodology: MEDLINE (PubMed) was searched from inception through 2021 for English language publications on APCs for facial rejuvenation.

Results: A total of 100 files were found. Based on the available literature, APCs for skin rejuvenation are safe and well tolerated. The most studied product is the first-generation material, platelet-rich plasma (PRP).

Conclusions: The results are in general favorable, but the quality of the studies is low. The second and third generation products, platelet-rich fibrin (PRF) and injectable platelet-rich fibrin (i-PRF), respectively, are easier to be obtained and, at least in vitro , seem to induce greater collagen production than PRP, especially under lower relative centrifugation forces, but to date only a few clinical trials evaluating these products exist. More high-quality trials with appropriate follow-up are necessary to provide adequate evidence that may help to improve the treatment regimens with APCs. Many aspects should be considered when designing clinical trials to evaluate APCs, such as the patients' characteristics that best predict a favorable response, the optimal number of sessions and the interval between them, the characteristics of the studies and the development of better instruments to evaluate skin aging.

Citing Articles

An International Survey on the Use of a Polyrevitalizing Solution With or Without Other Aesthetic Procedures in the Daily Practice of Aesthetic Physicians.

Fanian F, Casabona G, Bartoletti E, Cartier H, Landau M, Galadari H J Cosmet Dermatol. 2025; 24(2):e16623.

PMID: 39840703 PMC: 11837238. DOI: 10.1111/jocd.16623.


Platelet-rich plasma alleviates skin photoaging by activating autophagy and inhibiting inflammasome formation.

Huang Z, Gu Z, Zeng Y, Zhang D Naunyn Schmiedebergs Arch Pharmacol. 2025; .

PMID: 39836253 DOI: 10.1007/s00210-025-03800-0.


Impact of regenerative procedure on the healing process following surgical root canal treatment: A systematic review and meta-analysis.

Muthanna N, Guan X, Alzahrani F, Saif B, Seyam A, Alsalman A PLoS One. 2025; 20(1):e0312751.

PMID: 39746110 PMC: 11695025. DOI: 10.1371/journal.pone.0312751.


L-PRF in extra-oral wound care.

Pinto N, Yu J, Koirala S, Mourao C, Andrade C, Rescigno E Periodontol 2000. 2024; 97(1):342-362.

PMID: 39305000 PMC: 11808448. DOI: 10.1111/prd.12605.


Systematic Review of Platelet-Rich Plasma in Medical and Surgical Specialties: Quality, Evaluation, Evidence, and Enforcement.

Rahman E, Rao P, Abu-Farsakh H, Thonse C, Ali I, Upton A J Clin Med. 2024; 13(15).

PMID: 39124838 PMC: 11313071. DOI: 10.3390/jcm13154571.


References
1.
Cho E, Park G, Park S, Jang Y, Kim K, Kim K . Effect of platelet-rich plasma on proliferation and migration in human dermal fibroblasts. J Cosmet Dermatol. 2018; 18(4):1105-1112. DOI: 10.1111/jocd.12780. View

2.
Knighton D, Ciresi K, Fiegel V, Austin L, Butler E . Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg. 1986; 204(3):322-30. PMC: 1251286. DOI: 10.1097/00000658-198609000-00011. View

3.
da Silva L, Cancela R, Montalvao S, Huber S, Vieira-Damiani G, Triglia R . The effect of lyophilized platelet rich-plasma on skin aging: a non-randomized, controlled, pilot trial. Arch Dermatol Res. 2021; 313(10):863-871. DOI: 10.1007/s00403-021-02186-2. View

4.
Magalon J, Bausset O, Serratrice N, Giraudo L, Aboudou H, Veran J . Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model. Arthroscopy. 2014; 30(5):629-38. DOI: 10.1016/j.arthro.2014.02.020. View

5.
El Bagdadi K, Kubesch A, Yu X, Al-Maawi S, Orlowska A, Dias A . Reduction of relative centrifugal forces increases growth factor release within solid platelet-rich-fibrin (PRF)-based matrices: a proof of concept of LSCC (low speed centrifugation concept). Eur J Trauma Emerg Surg. 2017; 45(3):467-479. PMC: 6579868. DOI: 10.1007/s00068-017-0785-7. View